The U.S. Food and Drug Administration has approved Insmed's oral drug for a type of lung disease, the company said on Tuesday ...

A first-in-class reversible dipeptidyl peptidase-1 (DPP-1) inhibitor, brensocatib addresses the underlying inflammatory ...

Brinsupri, which Insmed acquired from AstraZeneca nearly a decade ago, is the first treatment for bronchiectasis that’s not ...

The spinout, known as Celea Therapeutics, will advance what’s designed to be an improved version of the drug pirfenidone for ...

Insmed has received FDA clearance for the first treatment for a chronic lung disease, opening the biotech up to what could be ...

For most Americans, the letters "NTM" don’t mean anything. But for tens of thousands of people across the country, they ...

A Legionnaires' disease cluster in the Harlem area of New York City has caused three deaths and 90 people to be sickened.

Todd and Julie Chrisley revealed that she developed a lung condition while they were incarcerated for 28 months, claiming ...

"Chrisley Knows Best" star Julie Chrisley claimed on her podcast she has a lung condition caused by asbestos exposure while ...

The U.S. Food and Drug Administration has approved Insmed's oral drug for a type of lung disease, the company said on Tuesday ...

The U.S. Food and Drug Administration (FDA) on Tuesday approved Insmed Incorporated’s (NASDAQ:INSM) Brinsupri (brensocatib 10 ...